Human cytomegalovirus: Host immune modulation by the viral US3 gene

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 3, 2009, Pages 503-506

  Liu, Ziqi ^a   Winkler, Michael ^b   Biegalke, Bonita ^c  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c OHIO UNIVERSITY   (United States)

Author keywords

Cytomegalovirus; Immune evasion; MHC class I heavy chains; Tapasin; US3

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; US3 PROTEIN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; AUTOREGULATION; ENDOPLASMIC RETICULUM; GENE; GENE EXPRESSION; HUMAN CYTOMEGALOVIRUS; IMMUNOMODULATION; NONHUMAN; OPEN READING FRAME; PROTEIN BINDING; PROTEIN INTERACTION; SHORT SURVEY; US3 GENE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, CELLULAR; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 58149308480     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.10.012     Document Type: Short Survey

References (28)

1. Ahn K.S., Angulo A., Ghazal P., Peterson P.A., Yang Y., and Früh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93 (1996) 10990-10995
2. American Society of Transplant Surgeons. Cytomegalovirus. Am J Transplant 4 (2004) 51-58
3. Biegalke B.J. Regulation of human cytomegalovirus US3 gene transcription by a cis-repressive sequence. J Virol 69 (1995) 5362-5367
4. Biegalke B.J., Lester E., and Rana R. Characterization of the human cytomegalovirus UL34 gene. J Virol 78 (2004) 9579-9583
5. Boppana S.B., Fowler K.B., Pass R.F., Rivera L.B., Bradford R.D., Lakeman F.D., et al. Congenital cytomegaloviurs infection: association between virus burden in infancy and hearing loss. J Pediatr 146 (2005) 817-823
6. Britt W.J., and Alford C.A. Cytomegalovirus. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (1996), Lippincott-Raven, Philadelphia 2493-2524
7. Castillo J.P., and Kowalik T.F. HCMV infection: modulating the cell cycle and cell death. Int Rev Immunol 23 (2004) 113-139
8. Chan Y.J., Tseng W.P., and Hayward G.S. Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus. J Virol 70 (1996) 5312-5328
9. Griffiths P.D. CMV as a cofactor enhancing progression of AIDS. J Clin Virol 35 (2006) 489-492
10. Gruhler A., Peterson P.A., and Fruh K. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association. Traffic 1 (2002) 318-325
11. Heemels M.-T., and Ploegh H. Generation, translocation and presentation of MHC class I-restricted peptides. Annu Rev Biochem 64 (1995) 463-491
12. Jones T.R., Wiertz E.J.H.J., Sun L., Fish K.N., Nelson J.A., and Ploegh H.L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93 (1996) 11327-11333
13. LaPierre L., and Biegalke B.J. Identification of a novel transcriptional repressor encoded by human cytomegalovirus. J Virol 75 (2001) 6062-6069
14. Lee S., Yoon J., Park B., Jun Y., Jin M., Sung H., et al. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. J Virol 74 (2000) 11262-11269
15. Lee S., Park B., and Ahn K. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. J Virol 77 (2003) 2147-2156
16. Liu W., Zhao Y., and Biegalke B.J. Analysis of human cytomegalovirus US3 gene products. Virology 301 (2002) 32-42
17. Misaghi S., Sun Z.-Y.J., Stern P., Gaudet R., Wagner G., and Ploegh H. Structural and functional analysis of human cytomegalovirus US3 protein. J Virol 78 (2004) 413-423
18. Mocarski E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10 (2002) 332-339
19. Murphy E., and Shenk T. Human cytomegalovirus genome. Curr Topics Microbiol Immun 325 (2008) 2-19
20. Pande N.T., Powers C., Ahn K., and Früh K. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 79 (2005) 5786-5798
21. Park B., Kim Y., Shin J., Lee S., Cho K., Früh K., et al. Human cytomegalovirus inhabits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20 (2004) 71-85
22. Park B., Sungwook L., Kin E., Cho K., Riddell S.R., Cho S., et al. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127 (2006) 369-382
23. Powers C., DeFelippis V., Malouli D., and Fruh K. Cytomegalovirus immune evasion. Curr Topics Microbiol Immun 325 (2008) 333-359
24. Shin J., Park B., Kim Y., Biegalke B.J., Kang S., and Ahn K. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form. J Virol 80 (2006) 5397-5404
25. Tenney D.J., Santomenna L.D., Goudie K.B., and Colberg-Poley A.M. The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression. Nucleic Acids Res 21 (1993) 2931-2937
26. Thrower A.R., Bullock G.C., Bissell J.E., and Stinski M.F. Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. J Virol 70 (1996) 91-100
27. Weston K. An enhancer element in the short unique region of human cytomegalovirus regulates the production of a group of abundant immediate early transcripts. Virology 162 (1988) 406-416
28. Zhao Y., and Biegalke B.J. Functional analysis of the human cytomegalovirus immune evasion protein, pUS322 kDa. Virology 315 (2003) 353-361